Aarti Drugs reports 12% fall in Q4 consolidated net profit

17 May 2021 Evaluate

Aarti Drugs has reported results for fourth quarter and year ended March 31, 2021.

The company has reported 11.17% fall in its net profit at Rs 50.24 crore for the quarter under review as compared to Rs 56.56 crore for the same quarter in the previous year. However, total income of the company increased by 11.23% at Rs 452.93 crore for Q4FY21 as compared Rs 407.19 crore for the corresponding quarter previous year.

On the consolidated basis, the company has reported 12.25% fall net profit attributable to owners at Rs 51.65 crore for the quarter under review as compared to Rs 58.86 crore for the same quarter in the previous year. However, total income of the company increased by 11.56% at Rs 502.72 crore for Q4FY21 as compared Rs 450.63 crore for the corresponding quarter previous year.

For the year ended March 31, 2021, the company has reported a rise of 89.95% in its net profit at Rs 257.71 crore as compared to Rs 135.67 crore for the previous year. Total income of the company increased by 17.44% at Rs 1921.31 crore for year under review as compared to Rs 1635.98 crore for year ended March 31, 2020.

For the year ended March 31, 2021, on the consolidated basis, the company has reported a rise of 98.31% in its net profit attributable to owners at Rs 280.41 crore as compared to Rs 141.40 crore for the previous year. Total income of the company increased by 19.46% at Rs 2159.30 crore for year under review as compared to Rs 1807.57 crore for year ended March 31, 2020.

Aarti Drugs Share Price

396.75 -8.20 (-2.02%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×